News | October 09, 2008

Study Shows CTA Effective Alternative for Confirmation of ICA Occlusions

October 10, 2008 - A recent study published in the October issue of Journal of Neuroimaging showed CT angiography (CTA) to be an effective, cost-saving alternative to standard catheter angiography for confirmation of internal carotid artery (ICA) occlusions.

The study was conducted by researchers with the University of Michigan’s Stroke Program.

Led by Devin Brown, M.D., the research team constructed a decision-analytic model to determine the cost benefits of CTA compared with catheter angiography in a hypothetical cohort of patients initially presenting with an ICA. The use of CTA was deemed cost-saving, demonstrating an overall net savings of $2,353 per patient ($9,178 vs. $11,531). Regarding effectiveness, CTA and catheter angiography produced similar levels of success, with CTA resulting in an additional 1.83 quality-adjusted life years, while catheter angiography accrued 1.82. Costs were estimated based on standard Medicare reimbursement statistics, while effectiveness was measured in quality-adjusted life years.

“Over the years, access to high quality medical imaging has become a critical factor in stroke prevention, and this study shows that the use of innovative technology can help lower overall treatment costs as well,” said Maureen Zilly, director, Government Relations, MITA (Medical Imaging & Technology Alliance). “MITA applauds the work of Dr. Devin Brown and his team, whose findings remind us how essential it is that patients and doctors alike have access to life-saving, cost-effective diagnostic imaging when dealing with serious conditions such as stroke."

This unique study is reportedly the first cost-effectiveness analysis related to carotid disease that has considered CTA as a factor.

“Given rising healthcare costs, cost-minimizing diagnostic strategies need to be explored,” wrote Dr. Brown. “This analysis suggests that CTA can be used as a less expensive alternative to [catheter angiography] for confirmation of a suspected ICA occlusion, without sacrificing patient outcome.”

For more information: www.medicalimaging.org


Related Content

News | CT Angiography (CTA)

Oct. 27, 2025 — At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting in San Francisco, Royal ...

Home October 30, 2025
Home
News | CT Angiography (CTA)

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of ...

Home October 29, 2025
Home
News | CT Angiography (CTA)

Oct. 22, 2025 — Qure has announced its latest (510) K clearance from the US Food and Drug Administration (FDA). The ...

Home October 23, 2025
Home
News | CT Angiography (CTA)

Sept. 2, 2025 — GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Home September 09, 2025
Home
News | CT Angiography (CTA)

Aug. 11, 2025 — Elucid announced that United Healthcare has updated its cardiac imaging guidelines to align with recent ...

Home August 11, 2025
Home
News | CT Angiography (CTA)

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz ...

Home May 02, 2025
Home
News | CT Angiography (CTA)

May 1, 2025 — A new expert opinion document jointly released by the Society for Cardiovascular Angiography and ...

Home May 01, 2025
Home
Feature | CT Angiography (CTA) | By Melinda Taschetta-Millane

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and ...

Home March 07, 2024
Home
News | CT Angiography (CTA)

January 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary solutions ...

Home January 23, 2024
Home
News | CT Angiography (CTA)

January 11, 2024 — According to the American Journal of Roentgenology (AJR), photon-counting detector (PCD) CT with ...

Home January 11, 2024
Home
Subscribe Now